March 20, 2018 12:00 AM ET


Company Overview of Extract Pharmaceuticals Inc.

Company Overview

Extract Pharmaceuticals, Inc. engages in the development of products based on chewing gum delivery of medicinal cannabis oils. The company was formerly known as Pacific Media Group Enterprises, Inc. and changed its name to Extract Pharmaceuticals, Inc. in April 2017. Extract Pharmaceuticals, Inc. was founded in 2014 and is based in San Diego, California.

3952 Clairemont Mesa Boulevard

Suite D-194

San Diego, CA 92117

United States

Founded in 2014





Key Executives for Extract Pharmaceuticals Inc.

President, CFO & Director
Age: 60
Compensation as of Fiscal Year 2017.

Extract Pharmaceuticals Inc. Key Developments

Token Communities, Ltd. Announces Executive Changes

On February 26, 2018, the shareholders of the Token Communities, Ltd. elected a new Board of Directors to the Company as follows: Alexander Lightman, has been appointed as Chief Executive Officer. He shall continue in his role as Chief Executive Officer of Token Communities PLC, as it is now a wholly owned subsidiary and operating unit of the company. He is Chief Strategist for Passport Cities and an advisor to several ICOs, including Guardian Circle’s Guardium, Phireon Global Partners, and Science Incubator ICO. Steven Knight, was appointed as Director and Chairman of the Board, and shall also continue in his role as Chairman of Token Communities PLC, based in Gibraltar where he has operated as the Chairman of Castle Trust Group for twenty-five years. He was appointed to start up and manage the Gibraltar office of Price Waterhouse in 1989. He established the Castle Group in 1992. Peter Maddocks, shall step down from the CEO position and will continue to serve as President and as Chief Financial Officer of the company.

Extract Pharmaceuticals Inc. announced delayed 10-Q filing

On 11/14/2017, Extract Pharmaceuticals Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Extract Pharmaceuticals Inc. announced delayed annual 10-K filing

On 09/29/2017, Extract Pharmaceuticals Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

February 26, 2018
April 12, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Extract Pharmaceuticals Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at